Sign In
Buy BCDA
$0.82
+0.0531 (+6.89%)
At Close: Jul 31, 2026
BioCardia Announces Clinical Leadership Changes
08:30am, Wednesday, 17'th Feb 2021
SAN CARLOS, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announ
Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
01:54pm, Friday, 05'th Feb 2021
Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
BioCardia Update on Cell Therapy Product Development and 2021 Milestones
08:30am, Tuesday, 02'nd Feb 2021
SAN CARLOS, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today provide
Accomplished Biotech Executive Krisztina Zsebo, Ph.D. Joins BioCardia's Board of Directors
08:30am, Monday, 11'th Jan 2021
SAN CARLOS, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, welcomes Kri
Why These Health Care Stocks Are Moving Today
02:03pm, Wednesday, 30'th Dec 2020
Altimmune (NASDAQ: ALT) shares were trading higher Wednesday after the company announced it began a multinational Phase 2 clinical trial of HepTcellTM for the treatment of chronic Hepatitis B. Altimm
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
08:30am, Wednesday, 30'th Dec 2020
Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and Structural Heart Procedures Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and St
BioCardia's stock pulls back after taking advantage of recent doubling with another share sale
09:55am, Wednesday, 16'th Dec 2020
Shares of BioCardia Inc. sank 13.9% in morning trading Wednesday, after the developer of regenerative biologic therapies announced more stock sales in the wake of the 137.6% rocket ride over the past
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08:30am, Wednesday, 16'th Dec 2020
SAN CARLOS, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA) (BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for th
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Revised]
01:21am, Tuesday, 15'th Dec 2020
SAN CARLOS, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for the
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
03:21pm, Monday, 14'th Dec 2020
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for the
BioCardia News: Why BCDA Stock Is Soaring Today
01:37pm, Monday, 14'th Dec 2020
BioCardia (BCDA) news for Monday includes an announcement concerning interim clinical trial results boosting BCDA stock higher. The post BioCardia News: Why BCDA Stock Is Soaring Today appeared first
Why BioCardia, Pacific Biosciences And HCA Are Trading Higher Today
12:23pm, Monday, 14'th Dec 2020
BioCardia (NASDAQ: BCDA) shares are trading higher. The company said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Tr
SAN CARLOS, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] today announced that the Company's proprietary Helix Biotherapeutic Delivery System (the Helix System) demonstra
BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights
07:00am, Tuesday, 10'th Nov 2020
SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and bu
12 Healthcare Stocks Moving In Thursday's After-Market Session
12:00am, Thursday, 22'nd Oct 2020
Gainers
Cassava Sciences (NASDAQ:SAVA) stock rose 20.61% to $10.65 during Thursday's after-market session. Today's trading volume for this security ended up closing at 271...
